Michael Solomon Email & Phone Number

Pleasanton, Ca, Us

StrategyDx is a full-service consulting company focused on business strategies for diagnostic and life science companies. With over 20 years of experience across multiple vertical market segments, StrategyDx provides companies with expert advice and guidance.

Hayward, California, Us

Kryptos Biotechnologies is developing a diagnostic platform for infectious disease and single cell analysis based on its core technology, photothermal heating technology.Responsible for helping guide development and commercialization of an instrument and cartridge based molecular diagnostics system for the detection of SARS-CoV-2.

Norcross, Ga, Us

Recipient of a CEO award for performance and accomplishments in 2017 and promoted to Director of Marketing in January of 2018.>First commercial team member for the MIA FORA Next Generation Sequencing HLA Typing product developed by Sirona Genomics (purchased by Immucor in March of 2016). MIA FORA represents the highest potential growth product within the Transplant segment. >Responsible for relaunching the kSORT Assay, a non-invasive gene expression assay to monitor patients for rejection post kidney transplant.>Handle all worldwide, upstream marketing activities for the NGS product for HLA typing and kSORT product lines.>Conduct market research, formulate recommendations for follow on products to guide R & D teams, and develop product roadmaps for MIA FORA and kSORT

Union City, Ca, Us

Over eight-year tenure, focused on strengthening competitive market position of point-of-care technology developer through the expansion of product portfolio and new market opportunities. Administered million-dollar annual budget and built and mentored product management team.> Conducted and authored multiple market assessment reports for various products and services, including quantitative market research, financial modeling and pricing analyses.> Lead two-year project in assessing, negotiating and launching a full service reference laboratory.> Participated on due diligence team for potential acquisition.

Chicago, Il, Us

Provided expertise in diagnostics markets to current Life Science team for multinational consulting firm.> Served as lead consultant on multiple diagnostic and life science research-based projects, including primary interviews with industry KOLs and quantitative online surveys.> Performed IP valuation project that resulted in spin-out of small company during an acquisition.> Conducted focus groups of primary care physicians and cardiologists in 10 cities for a large pharmaceutical company.> Conducted market assessments, created forecasting models, designed and executed quantitative online research studies for pharmaceutical companies in infectious disease, asthma, women’s health, epilepsy and OTC skin treatments.

Sunnyvale, Ca, Us

Focused on creating a profitable and market relevant molecular diagnostics company, with the goal of bringing diagnostic testing closer to the patient. Directed strategic and tactical marketing for full line of current and future products.> Developed and executed marketing plans for the first CLIA moderately complex molecular tests for Group B Strep and Enterovirus on the GeneXpert instrument.> Launched the Chronic Myologenous Leukemia RUO product on the GeneXpert Instrument platform.> Integral core team member for Xpert MRSA product.

Managed the Cystic Fibrosis ASR product and launched the remainder of the genetic testing product line for molecular diagnostics company. Interacted extensively with multiple business partners, vendors and distributors.> Handled the Cystic Fibrosis product line including all reagents and consumables.> Launched Hereditary Hemochromatosis and Factor V/II products.> Interacted with KOLs within the Cystic Fibrosis market to develop new, more comprehensive product for prenatal testing.

Ca, 92121, Us

Progressed from Research Associate within R&D, to Associate Product Manager of PACE Product Line, subsequently chosen as Product Manager for launch of the APTIMA Combo 2 STD product for molecular diagnostics company.> Maintained the PACE product line for C. trachomatis and N. gonorrhea, the market leader in molecular STD Diagnostics.> Successfully launched a tactical plan to integrate first and second generation molecular diagnostic assays by working closely with customers in hospitals, reference labs, and public health facilities.> Expanded C. trachomatis and N. gonorrhea testing applications by using alternative sample types and collection methods.> Member of strategic marketing team evaluating Gen-Probe technology in water and food testing market.

Executive Mba

Mph, Epidemiology

Bs, Biology